pca lda classification performance (Genovis Inc)
Genovis Inc is a verified supplier 
Genovis Inc manufactures this product 
93
Structured Review
Genovis Inc
pca lda classification performance
Pca Lda Classification Performance, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 92 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pca+lda+classification+performance/OpeRATOR+Lyophilized/frost_jonathan_a__2019__vibrational_spectroscopy_for_the_assessment_of_vulval_disease-2581-232-239
Average 93 stars, based on 92 article reviews
Pca Lda Classification Performance, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 92 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pca+lda+classification+performance/OpeRATOR+Lyophilized/frost_jonathan_a__2019__vibrational_spectroscopy_for_the_assessment_of_vulval_disease-2581-232-239
Average 93 stars, based on 92 article reviews
pca lda classification performance - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Microscopy:Article Title: Vibrational Spectroscopy for the Assessment of Vulval Disease Article Snippet: .. Figure 7-10 — SNR for increasing acquisition time for spectra taken from normal vulval skin ................................................................................................... 211 Figure 7-11 — PTFE spectrum, x50 objective, 10 sec integration time .................... 214 Figure 7-12 — Normalised counts of the 732 cm1 peak as the microscope focus advances towards the PTFE through different depths of Intralipid 2.48%, x50 objective, 605 integration time ................................................................................. 214 Figure 7-13 — Marking of punch biopsies (ink dot on left of the biopsy allows the pathologist to cut the specimen along the solid line, mount section A in paraffin and cut sections for staining and histology at the level marked with the dashed line) ...217 Figure 7-14 — First alternative method for selecting principal components within leave one sample out cross validated PCA LDA classification ......................................... 219 Figure 7-15 — Sub loop for determining the number of biological relevant PCs in the first alternative method for selecting PCs within leave one sample out cross validated PCA LDA classification ........................................................................................... 220 Figure 7-16 — Second alternative method for selecting principal components within the leave one sample out cross validated PCA LDA classification ......................... 222 Figure 7-17 — Sub loop for identifying the biological relevant PCs in the second alternative method for selecting PCs within leave one sample out cross validated PCA LDA classification .................................................................................. 222 Figure 7-18 — Histogram of score values from linear discriminant function ............ 225 Figure 7-19 — Staining:Article Title: Vibrational Spectroscopy for the Assessment of Vulval Disease Article Snippet: .. Figure 7-10 — SNR for increasing acquisition time for spectra taken from normal vulval skin ................................................................................................... 211 Figure 7-11 — PTFE spectrum, x50 objective, 10 sec integration time .................... 214 Figure 7-12 — Normalised counts of the 732 cm1 peak as the microscope focus advances towards the PTFE through different depths of Intralipid 2.48%, x50 objective, 605 integration time ................................................................................. 214 Figure 7-13 — Marking of punch biopsies (ink dot on left of the biopsy allows the pathologist to cut the specimen along the solid line, mount section A in paraffin and cut sections for staining and histology at the level marked with the dashed line) ...217 Figure 7-14 — First alternative method for selecting principal components within leave one sample out cross validated PCA LDA classification ......................................... 219 Figure 7-15 — Sub loop for determining the number of biological relevant PCs in the first alternative method for selecting PCs within leave one sample out cross validated PCA LDA classification ........................................................................................... 220 Figure 7-16 — Second alternative method for selecting principal components within the leave one sample out cross validated PCA LDA classification ......................... 222 Figure 7-17 — Sub loop for identifying the biological relevant PCs in the second alternative method for selecting PCs within leave one sample out cross validated PCA LDA classification .................................................................................. 222 Figure 7-18 — Histogram of score values from linear discriminant function ............ 225 Figure 7-19 — |